Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Revvity Inc. RVTY

Healthcare  —  Diagnostics & Research
151.11 0.43 0.29% as of 25 Sep
Market cap
$16.8B
P/E
72.0×
S&P 500 Member Dividend Aristocrat
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Revvity Inc. (RVTY) EV/EBITDA

As of 25 September 2026, Revvity Inc. (RVTY) trades at a EV/EBITDA of 24.5×. Over the past ten years it has ranged from 10.5× (May 2021) to 27.0× (September 2018); the current reading is higher than 97% of that period. That is in line with the Diagnostics & Research industry median of 25.2× and above the Healthcare sector median of 10.4×.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2025 17.7× (11.87%)
FY2024 20.1× (7.49%)
FY2023 21.7× 22.10%
FY2022 17.8× 3.27%
FY2021 17.2× 5.19%
FY2020 16.4× (22.10%)
FY2019 21.0× 6.41%
FY2018 19.8× (18.50%)
FY2017 24.2× 48.34%
FY2016 16.3× (12.30%)

Quarterly

Period EV/EBITDA Change
Jun 2026 18.8× 20.50%
Mar 2026 15.6× (11.83%)
Dec 2025 17.7× 10.77%
Sep 2025 16.0× (6.15%)
42 more quarters

Against its own ten years

Low 10.5× High 27.0×
Ten-year median 19.4×
Current reading's percentile 97

EV/EBITDA against peers

Company EV/EBITDA
GH Guardant Health, Inc. compare n/m
TWST Twist Bioscience Corporation compare n/m
DGX Quest Diagnostics Incorporated compare 14.1×
LH Labcorp Holdings Inc. compare 14.7×
ICLR ICON PLC compare 23.5×
RVTY Revvity Inc. 24.5×
MTD Mettler-Toledo International, Inc. compare 24.9×
MEDP Medpace Holdings, Inc. compare 28.0×
CRL Charles River Laboratories International, Inc. compare 29.8×
Diagnostics & Research industry median 25.2×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on RVTY